Equities research analysts at StockNews.com assumed coverage on shares of Mannatech (NASDAQ:MTEX – Get Free Report) in a report issued on Sunday. The firm set a “buy” rating on the stock.
Mannatech Price Performance
Mannatech stock opened at $11.30 on Friday. The company has a market cap of $21.48 million, a price-to-earnings ratio of -13.95 and a beta of 0.98. Mannatech has a 52-week low of $6.75 and a 52-week high of $16.49. The company has a quick ratio of 0.74, a current ratio of 1.25 and a debt-to-equity ratio of 0.44. The firm’s fifty day moving average is $10.04 and its 200 day moving average is $10.37.
Mannatech (NASDAQ:MTEX – Get Free Report) last posted its quarterly earnings data on Wednesday, March 26th. The company reported $1.20 EPS for the quarter. The company had revenue of $29.01 million during the quarter. Mannatech had a negative net margin of 1.26% and a negative return on equity of 15.62%.
Mannatech Company Profile
Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.
Further Reading
- Five stocks we like better than Mannatech
- What is Forex and How Does it Work?
- Best Defense Stocks in 2025… So Far
- What Investors Need to Know to Beat the Market
- Alphabet Rebounds After Strong Earnings and Buyback Announcement
- Short Selling – The Pros and Cons
- Could Selling Taiwan Semiconductor Be Buffett’s Biggest Regret?
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.
